University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 11 of 23
Gabapentin for Postop Pain After SSLF
NCT03123861
Daily Step-based Exercise Using Fitness Monitors for Peripheral Artery Disease
NCT03099369
Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)
NCT02782325
Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)
NCT02932475
Non-Invasive Brain Stimulation and Substance Use
NCT03122587
ARDS Esophageal Balloon Pressure Changes With Positioning Study
NCT03120793
Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma
NCT02891317
Clinical Outcomes Mandible: Buffered 1% vs. Non-Buffered 1% Lidocaine
NCT03127943
Postural Changes During Right Heart Catheterization
NCT03089164
Pharmacokinetics of Apixaban in Nephrotic Syndrome
NCT02599532
Human Biological Responses to Low Level Ozone
NCT02857283
Cochlear Implantation in Pediatric Cases of Unilateral Hearing Loss
NCT02963974
Prediction of Functional Outcomes From Chronic Critical Illness
NCT03159208
Reducing Cardiovascular Disease Risk Factors in Rural Communities in North Carolina
NCT02707432
Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.
NCT03023397
A Web-based Tailored Health Behavior Intervention for Breast and Colon Cancer Survivors (eWellness)
NCT04188002
Reducing Postoperative Catheterization
NCT03009968
Characterization of Airway Mucus in Bronchiectasis Patients and Healthy Controls
NCT03125174
Cranial Laser Reflex Technique for Hamstring Function
NCT03044106
Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder
NCT02909959
Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients
NCT03020589
Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis
NCT03078127
Nitrous Oxide for External Cephalic Version
NCT03502915
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
NCT03037567
Geniculate Artery Embolization for the Treatment of Knee Pain
NCT02850068
The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood
NCT03003949
Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening
NCT02991729
Role of Rehabilitation in Concussion Management: A Randomized Controlled Trial
NCT02988596
High Intensity Interval Training in Osteoarthritis, Effects on Metabolomics
NCT03039452
Full-arch Monolithic Zirconia ISFDP Follow up
NCT02931968
Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality
NCT03720847
Large-scale Brain Organization During Cognitive Control in ADHD
NCT04349917
Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics
NCT03117582
An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
NCT02842073
Botanical Supplement Muscle Function and Lean Body Mass
NCT03034668
Sex Hormone Therapy and Mucosal Tissues
NCT02983110
Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy
NCT03067311
Anticipated and Perceived Benefits Following Hepatitis C Treatment
NCT03000023
Protein Supplementation Post Bariatric Surgery
NCT02951663
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
NCT02772965
Comparison of Two Gingival Displacement Procedures
NCT02716727
Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease
NCT02947022
Specialty Mental Health Probation in North Carolina
NCT02990026
The Effects of Safety Seeking Behaviors During Exposure Therapy for Adults With Spider Phobia
NCT03233113
Carolina Heart Alliance Networking for Greater Equity
NCT03582696
Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management
NCT02820038
Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure
NCT02911688
Impact of Cigarette Pack Constituent Disclosures
NCT02785484
Probiotics in Occupational Shift Workers
NCT02951689
Immediate Effects of rTMS on Excitability of the Quadriceps With Knee Osteoarthritis
NCT02881775
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.